GraphFusion was outperformed with large margin ( Figure 4 ), and the gain compared to sgSVM(meta) was still weakly/moderately significant ( for ovarian and for prostate cancer; Wilcoxon signed rank test).
← all excerpts
Network and data integration for biomarker signature discovery via network smoothed T-statistics.
1
—
—